RAD21 (O60216) variants and mutations
RAD21 (also known as O60216) is a human protein-coding gene encoding a double-strand-break repair protein rad21 homolog protein. It forms part of the cohesin ring that holds replicated chromosomes together and also helps organize three-dimensional chromatin and gene regulation. Haploinsufficiency causes a Cornelia-de-Lange-like developmental syndrome, while somatic mutations occur in myeloid cancers. This analysis covers 975 RAD21 variants and mutations. Of these, 65% have computational variant effect predictions. Disease context includes Cornelia de Lange syndrome, Mungan syndrome, and hereditary disease. Example RAD21 variants include M1?, M1I, and Y3*.
Variant analysis overview
- Gene: RAD21
- Protein: O60216
- UniProt accession: O60216
- Organism: Homo sapiens
- Variants analyzed: 975
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 766 unspecified-consequence records; 1 stop retained variant; 96 missense variants; 80 synonymous variants; 16 frameshift variants; 3 splice-region variants; 2 stop-gained variants; 7 in-frame deletions; 1 in-frame insertions; 3 substitution
- Prediction scores: 634 variants have prediction scores (65% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Cornelia de Lange syndrome, Mungan syndrome, hereditary disease, acute myeloid leukemia, neurodegenerative disease, lung carcinoma, hemangioblastoma, Septo-optic dysplasia, ovarian endometrioid adenocarcinoma with squamous differentiation, carcinoma of liver and intrahepatic biliary tract, bile duct carcinoma, hepatobiliary neoplasm.
Protein structure and variant hotspots
- Protein features: 8 post-translational modification sites.
- PTM context: 12 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable RAD21 variants
Examples include M1?, M1I, Y3*, Y3C, A4T, A4S, A4V, H5Y. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, cosmic curated COSV52057
- M1I (p.Met1Ile), rs1586276006, ClinGen CA372012317, ClinVar RCV000995851, Pathogenic, Cornelia de Lange syndrome 4
- Y3* (p.Tyr3Ter), rs758626942, ClinGen CA372012280, ClinVar RCV001293756, ExAC rs758626942, Likely pathogenic
- Y3C (p.Tyr3Cys), Ensembl rs775766535, REVEL 0.81, CADD 29.80
- A4T (p.Ala4Thr), Ensembl rs952925795, REVEL 0.29, CADD 26.90
- A4S (p.Ala4Ser), cosmic curated COSV52058
- A4V (p.Ala4Val), cosmic curated COSV52063
- H5Y (p.His5Tyr), TOPMed rs1047486234, REVEL 0.72, CADD 27.30
- V7F (p.Val7Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L8V (p.Leu8Val), cosmic curated COSV52058
- S9N (p.Ser9Asn), TOPMed rs1812700887
- R11L (p.Arg11Leu), cosmic curated COSV52061
- R11* (p.Arg11Ter), cosmic curated COSV52062
- R11I (p.Arg11Ile), cosmic curated COSV10942
- K16R (p.Lys16Arg), TOPMed rs1252270592, gnomAD rs1252270592, REVEL 0.30, CADD 24.50
- I17N (p.Ile17Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- I17S (p.Ile17Ser), TOPMed rs1812700650, gnomAD rs1812700650, REVEL 0.80, CADD 29.70
- W18G (p.Trp18Gly), rs2537309018, ClinGen CA372012023, ClinVar RCV003380950, REVEL 0.73, CADD 32.00, Uncertain significance, Inborn genetic diseases
- L19F (p.Leu19Phe), cosmic curated COSV10644
- A20V (p.Ala20Val), NCI-TCGA Cosmic COSV5206, TOPMed rs1812700564, Variant assessed as somatic; moderate impact.
- W23* (p.Trp23Ter), rs1804043, ClinGen CA184279587, ClinVar RCV003988796, Ensembl rs1804043, Pathogenic
- K25E (p.Lys25Glu), gnomAD rs1204046708, REVEL 0.56, CADD 29.60
- K29T (p.Lys29Thr), NCI-TCGA Cosmic COSV5205, Variant assessed as somatic; moderate impact.
- A30V (p.Ala30Val), TOPMed rs1280565991, gnomAD rs1280565991, REVEL 0.29, CADD 25.40
- V32L (p.Val32Leu), gnomAD rs1812699937, REVEL 0.34, CADD 25.80, Uncertain significance, not provided
- F33L (p.Phe33Leu), cosmic curated COSV10462
- E34* (p.Glu34Ter), cosmic curated COSV52058
- E34Q (p.Glu34Gln), NCI-TCGA Cosmic COSV5206, Variant assessed as somatic; moderate impact.
- C35R (p.Cys35Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N36D (p.Asn36Asp), gnomAD rs1234402375
- E38* (p.Glu38Ter), 1000Genomes rs199654282
- S39I (p.Ser39Ile), cosmic curated COSV99814
- S39T (p.Ser39Thr), cosmic curated COSV52060
- V41L (p.Val41Leu), Ensembl rs769975600, Uncertain significance, RAD21-related disorder
- V41M (p.Val41Met), NCI-TCGA Cosmic COSV5205, Ensembl rs769975600, REVEL 0.54, CADD 26.90, Variant assessed as somatic; moderate impact.
- E42G (p.Glu42Gly), TOPMed rs1586275923
- E42Q (p.Glu42Gln), NCI-TCGA Cosmic COSV5205, Variant assessed as somatic; moderate impact.
- E42V (p.Glu42Val), TOPMed rs1586275923
- S43N (p.Ser43Asn), ExAC rs762402509, gnomAD rs762402509, REVEL 0.12, CADD 26.30
- I45V (p.Ile45Val), cosmic curated COSV52056
- P47L (p.Pro47Leu), cosmic curated COSV52057
- P47S (p.Pro47Ser), cosmic curated COSV99814
- K48E (p.Lys48Glu), cosmic curated COSV99815
- M51I (p.Met51Ile), NCI-TCGA Cosmic COSV5206, Variant assessed as somatic; moderate impact.
- L53P (p.Leu53Pro), cosmic curated COSV10644
- R54G (p.Arg54Gly), rs2130479466, ClinGen CA372011014, ClinVar RCV001769504, Ensembl rs2130479466, Uncertain significance, not provided
- R54Q (p.Arg54Gln), rs1563692624, NCI-TCGA Cosmic COSV5205, NCI-TCGA Cosmic COSV5206, Ensembl rs1563692624, REVEL 0.74, CADD 30.00, Variant assessed as somatic; moderate impact.
- R54W (p.Arg54Trp), rs2130479466, ClinGen CA372011012, NCI-TCGA Cosmic COSV5206, ClinVar RCV003397389, REVEL 0.65, CADD 31.00, Conflicting interpretations, Inborn genetic diseases; RAD21-related disorder; not provided
- S56* (p.Ser56Ter), ExAC rs761205243, gnomAD rs761205243, CADD 37.00
- S56P (p.Ser56Pro), NCI-TCGA Cosmic COSV5206, Variant assessed as somatic; moderate impact.
- L61T (p.Leu61Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- G62E (p.Gly62Glu), NCI-TCGA Cosmic COSV5205, Variant assessed as somatic; moderate impact.
- R65* (p.Arg65Ter), rs1812625715, ClinGen CA372010882, NCI-TCGA Cosmic COSV5205, ClinVar RCV003645955, Pathogenic
- R65G (p.Arg65Gly), rs1812625715, ClinGen CA372010884, ClinVar RCV002276190, Ensembl rs1812625715, Uncertain significance, not provided
- R65Q (p.Arg65Gln), rs773855925, ClinGen CA4853140, NCI-TCGA Cosmic COSV5205, ClinVar RCV000623219, REVEL 0.68, CADD 29.60, Uncertain significance, Inborn genetic diseases
- I66T (p.Ile66Thr), cosmic curated COSV52059
- Y67C (p.Tyr67Cys), Ensembl rs1812625618, REVEL 0.82, CADD 29.90
- K70* (p.Lys70Ter), rs1554612093, ClinGen CA372010797, ClinVar RCV000677715, Ensembl rs1554612093, Pathogenic
- K72R (p.Lys72Arg), Ensembl rs1812625472, REVEL 0.25, CADD 27.70
- L75I (p.Leu75Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N79D (p.Asn79Asp), rs1812625374, ClinGen CA372010602, ClinVar RCV001266970, Ensembl rs1812625374, Uncertain significance, Inborn genetic diseases
- E80* (p.Glu80Ter), NCI-TCGA Cosmic COSV5205, Variant assessed as somatic; high impact.
- A81S (p.Ala81Ser), NCI-TCGA Cosmic COSV5206, Variant assessed as somatic; moderate impact.
- F82I (p.Phe82Ile), NCI-TCGA Cosmic COSV5205, Variant assessed as somatic; moderate impact.
- F82V (p.Phe82Val), Ensembl rs1812625291
- I83T (p.Ile83Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- K84N (p.Lys84Asn), rs2130479393, ClinGen CA372010481, ClinVar RCV001757474, Ensembl rs2130479393, REVEL 0.34, CADD 23.70, Uncertain significance, not provided
- I85V (p.Ile85Val), TOPMed rs1383139643, gnomAD rs1383139643, REVEL 0.22, CADD 33.00
- R90L (p.Arg90Leu), NCI-TCGA Cosmic COSV5205, NCI-TCGA Cosmic COSV9981, REVEL 0.53, CADD 24.30, Variant assessed as somatic; moderate impact.
- R90P (p.Arg90Pro), NCI-TCGA Cosmic COSV5205, NCI-TCGA Cosmic COSV9981, Variant assessed as somatic; moderate impact.
- R90Q (p.Arg90Gln), rs1554612086, ClinGen CA372010372, NCI-TCGA Cosmic COSV5205, NCI-TCGA Cosmic COSV9981, Uncertain significance, not specified
- R90W (p.Arg90Trp), rs1057522888, ClinGen CA16605433, NCI-TCGA Cosmic COSV5205, ClinVar RCV000418359, REVEL 0.61, CADD 26.70, Uncertain significance, not provided; Cornelia de Lange syndrome 4
- P91R (p.Pro91Arg), TOPMed rs1028059920, REVEL 0.59, CADD 32.00
- E98Q (p.Glu98Gln), NCI-TCGA Cosmic COSV5205, Variant assessed as somatic; moderate impact.
- R101Q (p.Arg101Gln), gnomAD rs1396596588, REVEL 0.32, CADD 27.90
- N106D (p.Asn106Asp), Ensembl rs763531440
- A107T (p.Ala107Thr), Ensembl rs74589731, Uncertain significance, not provided
- A107V (p.Ala107Val), Ensembl rs77749836
- P111L (p.Pro111Leu), TOPMed rs1188855849
- E112* (p.Glu112Ter), NCI-TCGA Cosmic COSV9981, Variant assessed as somatic; high impact.
- E113* (p.Glu113Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- F114C (p.Phe114Cys), NCI-TCGA Cosmic COSV5206, Variant assessed as somatic; moderate impact.
- D118N (p.Asp118Asn), TOPMed rs1812599700
- Q119H (p.Gln119His), rs763028310, ClinGen CA4853114, ClinVar RCV001757318, ClinVar RCV006467900, REVEL 0.23, CADD 23.90, Uncertain significance, Cornelia de Lange syndrome 4; not provided
- D123H (p.Asp123His), ExAC rs775698541, gnomAD rs775698541, REVEL 0.61, CADD 28.30
- D123Y (p.Asp123Tyr), NCI-TCGA Cosmic COSV5206, REVEL 0.68, CADD 29.10, Variant assessed as somatic; moderate impact.
- D125H (p.Asp125His), NCI-TCGA Cosmic COSV5206, REVEL 0.22, CADD 32.00, Variant assessed as somatic; moderate impact.
- D126G (p.Asp126Gly), NCI-TCGA Cosmic COSV9981, Variant assessed as somatic; moderate impact.
- D126N (p.Asp126Asn), ExAC rs764298349, TOPMed rs764298349, gnomAD rs764298349, REVEL 0.28, CADD 31.00
- D128N (p.Asp128Asn), gnomAD rs1280702667, REVEL 0.29, CADD 28.10
- V129A (p.Val129Ala), rs1812516812, ClinGen CA372008382, ClinVar RCV003404637, Ensembl rs1812516812, REVEL 0.21, CADD 24.10, Uncertain significance, RAD21-related disorder
- V129L (p.Val129Leu), NCI-TCGA Cosmic COSV5206, Variant assessed as somatic; moderate impact.
- F133L (p.Phe133Leu), Ensembl rs61758754
- S134G (p.Ser134Gly), TOPMed rs1812516520, REVEL 0.09, CADD 23.90
- L135S (p.Leu135Ser), ExAC rs771053519, gnomAD rs771053519, REVEL 0.45, CADD 28.20
- S138G (p.Ser138Gly), TOPMed rs1269660025, gnomAD rs1269660025, REVEL 0.18, CADD 24.80, Uncertain significance, not provided
- S138R (p.Ser138Arg), gnomAD rs1403578012, REVEL 0.29, CADD 23.20
- V140M (p.Val140Met), rs1554611589, ClinGen CA372008062, ClinVar RCV000623395, ClinVar RCV004760651, Uncertain significance, Inborn genetic diseases; not provided
- E142* (p.Glu142Ter), NCI-TCGA Cosmic COSV5205, NCI-TCGA Cosmic COSV5206, Variant assessed as somatic; high impact.
- E142D (p.Glu142Asp), NCI-TCGA Cosmic COSV9981, Variant assessed as somatic; moderate impact.
- I143K (p.Ile143Lys), gnomAD rs1382274750, Likely pathogenic
- I143T (p.Ile143Thr), rs1382274750, ClinGen CA372007993, ClinVar RCV001091703, gnomAD rs1382274750, Likely pathogenic, not provided
- T144I (p.Thr144Ile), rs2537299262, ClinGen CA372007974, ClinVar RCV003646449, Uncertain significance, Cornelia de Lange syndrome 4
- M145L (p.Met145Leu), gnomAD rs1360712011, REVEL 0.18, CADD 22.10
- E147K (p.Glu147Lys), NCI-TCGA Cosmic COSV5206, Variant assessed as somatic; moderate impact.
- E147V (p.Glu147Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V149I (p.Val149Ile), gnomAD rs1286641507
- G150E (p.Gly150Glu), ExAC rs746850747, gnomAD rs746850747, REVEL 0.23, CADD 22.60
- G150V (p.Gly150Val), NCI-TCGA Cosmic COSV5206, Variant assessed as somatic; moderate impact.
- I152M (p.Ile152Met), gnomAD rs1173333551
- I152V (p.Ile152Val), rs897373910, TOPMed rs897373910, gnomAD rs897373910, REVEL 0.04, CADD 22.20, Variant assessed as somatic; moderate impact.
- S153G (p.Ser153Gly), TOPMed rs1414020923
- S153N (p.Ser153Asn), Ensembl rs868366731, REVEL 0.06, CADD 20.40
- I154T (p.Ile154Thr), NCI-TCGA Cosmic COSV5205, Variant assessed as somatic; moderate impact.
- Q156* (p.Gln156Ter), rs1812515682, ClinGen CA372007805, ClinVar RCV001052591, Ensembl rs1812515682, Pathogenic
- E157D (p.Glu157Asp), TOPMed rs1812515621, REVEL 0.07, CADD 16.40
- E157K (p.Glu157Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D159Y (p.Asp159Tyr), gnomAD rs1375276877, REVEL 0.38, CADD 25.30
- F160V (p.Phe160Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G161D (p.Gly161Asp), rs2537297912, ClinGen CA372007059, ClinVar RCV002820293, REVEL 0.11, CADD 24.30, Uncertain significance, Cornelia de Lange syndrome 4
- M165R (p.Met165Arg), gnomAD rs1231034554, REVEL 0.25, CADD 29.40
- D166G (p.Asp166Gly), rs1586268625, ClinGen CA372006993, ClinVar RCV000995850, Ensembl rs1586268625, REVEL 0.37, CADD 32.00, Likely pathogenic, Cornelia de Lange syndrome 4
- R168C (p.Arg168Cys), rs1337189031, NCI-TCGA Cosmic COSV5205, gnomAD rs1337189031, Variant assessed as somatic; moderate impact.
- R168H (p.Arg168His), rs772999578, NCI-TCGA Cosmic COSV5206, ExAC rs772999578, REVEL 0.11, CADD 23.00, Variant assessed as somatic; moderate impact.
- E169D (p.Glu169Asp), Ensembl rs1812492438, REVEL 0.15, CADD 19.80
- I170M (p.Ile170Met), gnomAD rs1308066942, REVEL 0.16, CADD 11.40, Uncertain significance, not provided
- M171I (p.Met171Ile), rs2537297880, ClinGen CA372006917, ClinVar RCV003533968, Uncertain significance, Cornelia de Lange syndrome 4
- E173G (p.Glu173Gly), TOPMed rs1285688510
- G174C (p.Gly174Cys), Ensembl rs1812492321, REVEL 0.14, CADD 24.20
- A176V (p.Ala176Val), TOPMed rs1324728772, gnomAD rs1324728772, REVEL 0.13, CADD 22.70
- E178* (p.Glu178Ter), NCI-TCGA Cosmic COSV5206, Variant assessed as somatic; high impact.
- E178D (p.Glu178Asp), TOPMed rs1586268607
- D179G (p.Asp179Gly), TOPMed rs1391244308, gnomAD rs1391244308, REVEL 0.10, CADD 23.00
- D180A (p.Asp180Ala), rs772085724, ClinGen CA4853058, ClinVar RCV000272825, ClinVar RCV002518982, REVEL 0.18, CADD 25.20, Uncertain significance, Inborn genetic diseases; not provided
- D180H (p.Asp180His), Ensembl rs1812492159, REVEL 0.20, CADD 26.40
- D181H (p.Asp181His), TOPMed rs1462000579, gnomAD rs1462000579, REVEL 0.09, CADD 22.60
- D181N (p.Asp181Asn), TOPMed rs1462000579, gnomAD rs1462000579, REVEL 0.06, CADD 22.40
- M182V (p.Met182Val), ExAC rs774348326, REVEL 0.07, CADD 19.50
- L183* (p.Leu183Ter), rs2537297841, ClinGen CA372006745, ClinVar RCV002466787, Likely pathogenic
- L183I (p.Leu183Ile), ExAC rs768586514, TOPMed rs768586514, gnomAD rs768586514
- V184L (p.Val184Leu), ESP rs371214924, ExAC rs371214924, gnomAD rs371214924, REVEL 0.05, CADD 18.60
- T186A (p.Thr186Ala), Ensembl rs1812491826, REVEL 0.08, CADD 19.00
- T187A (p.Thr187Ala), ExAC rs769141885, TOPMed rs769141885, gnomAD rs769141885, REVEL 0.05, CADD 18.40
- S189T (p.Ser189Thr), ExAC rs778115340, TOPMed rs778115340, gnomAD rs778115340, REVEL 0.12, CADD 22.20, Uncertain significance, Inborn genetic diseases
- N190T (p.Asn190Thr), TOPMed rs1429841397
- L193* (p.Leu193Ter), rs886041504, ClinGen CA10603084, ClinVar RCV000374189, Ensembl rs886041504, Pathogenic
- L193Y (p.Leu193Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- E194T (p.Glu194Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- S195P (p.Ser195Pro), rs755363046, ClinGen CA4853045, NCI-TCGA Cosmic COSV5206, ClinVar RCV003646786, REVEL 0.06, CADD 18.20, Uncertain significance, Cornelia de Lange syndrome 4
- Q197* (p.Gln197Ter), rs1352385210, ClinGen CA372006491, ClinVar RCV001072118, gnomAD rs1352385210, Pathogenic
- Q197E (p.Gln197Glu), gnomAD rs1352385210, REVEL 0.07, CADD 17.80, Pathogenic
- S198N (p.Ser198Asn), TOPMed rs905200346, gnomAD rs905200346, REVEL 0.06, CADD 21.30
- T199A (p.Thr199Ala), NCI-TCGA Cosmic COSV5206, Variant assessed as somatic; moderate impact.
- T199I (p.Thr199Ile), TOPMed rs1261006144, gnomAD rs1261006144, REVEL 0.06, CADD 22.60
- S200G (p.Ser200Gly), NCI-TCGA Cosmic COSV5205, Variant assessed as somatic; moderate impact.
- N201D (p.Asn201Asp), Ensembl rs1812491007, REVEL 0.06, CADD 19.70
- N203S (p.Asn203Ser), ExAC rs766673627, TOPMed rs766673627, gnomAD rs766673627, REVEL 0.08, CADD 19.10
- N203T (p.Asn203Thr), ExAC rs766673627, TOPMed rs766673627, gnomAD rs766673627
- E204D (p.Glu204Asp), TOPMed rs1230958195, gnomAD rs1230958195, REVEL 0.19, CADD 14.80, Uncertain significance, Inborn genetic diseases
- I206S (p.Ile206Ser), TOPMed rs1342945567, gnomAD rs1342945567, REVEL 0.10, CADD 22.50
- H208D (p.His208Asp), Ensembl rs1563690574, REVEL 0.23, CADD 21.70
- H208R (p.His208Arg), rs1586268513, ClinGen CA372006266, ClinVar RCV002586578, Ensembl rs1586268513, Uncertain significance, Cornelia de Lange syndrome 4
- H208Y (p.His208Tyr), NCI-TCGA Cosmic COSV5206, Variant assessed as somatic; moderate impact.
- E210* (p.Glu210Ter), rs2130469189, ClinGen CA372006224, ClinVar RCV001420218, Ensembl rs2130469189, Likely pathogenic
- E212D (p.Glu212Asp), TOPMed rs1812490472, gnomAD rs1812490472, REVEL 0.12, CADD 15.30
- D213E (p.Asp213Glu), NCI-TCGA Cosmic COSV5206, Variant assessed as somatic; moderate impact.
- D213N (p.Asp213Asn), Ensembl rs1358443424
- D213V (p.Asp213Val), rs1323894024, ClinGen CA372006154, ClinVar RCV003385112, gnomAD rs1323894024, REVEL 0.10, CADD 23.10, Uncertain significance, Inborn genetic diseases
- Q214E (p.Gln214Glu), rs767342502, ClinGen CA4853040, ClinVar RCV002007711, ExAC rs767342502, REVEL 0.15, CADD 23.40, Uncertain significance, Cornelia de Lange syndrome 4
- Q214K (p.Gln214Lys), NCI-TCGA Cosmic COSV5205, REVEL 0.23, CADD 23.90, Variant assessed as somatic; moderate impact.
- Y215* (p.Tyr215Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- Y215C (p.Tyr215Cys), TOPMed rs1305489448
- D217Y (p.Asp217Tyr), gnomAD rs1158262020, REVEL 0.49, CADD 27.10
- N224S (p.Asn224Ser), gnomAD rs1175308980, REVEL 0.07, CADD 18.70
- D225G (p.Asp225Gly), ESP rs373291241, ExAC rs373291241, TOPMed rs373291241, gnomAD rs373291241, REVEL 0.18, CADD 23.70
- D225H (p.Asp225His), Ensembl rs2130469141
- G226S (p.Gly226Ser), rs2537297697, ClinGen CA372005876, ClinVar RCV002619911, ClinVar RCV003134665, REVEL 0.17, CADD 23.70, Uncertain significance, Cornelia de Lange syndrome 4; not provided
- I228L (p.Ile228Leu), gnomAD rs1252368238, REVEL 0.12, CADD 21.70
- I228N (p.Ile228Asn), rs2537297690, ClinGen CA2697550112, ClinVar RCV003531583, Pathogenic
- L229F (p.Leu229Phe), rs774987531, ClinGen CA4853034, ClinVar RCV001922759, ExAC rs774987531, REVEL 0.21, CADD 25.30, Uncertain significance, Cornelia de Lange syndrome 4
Public RAD21 analysis runs
- RAD21 analysis run — RAD21 (975 variants) — completed 2026-08-19